V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010413 | 270006112 | 1.8 | 88.5 | Curative (C) | 2017-11-26 | 2017-11-27 | HD Lymph Pred EuroNet-PHL-LP1 CVP | 02 | N | 270024981 | CVP |
| 270010414 | 270006112 | 1.81 | null | Curative (C) | null | 2013-10-14 | CAP + RT | null | null | 270024981 | OXALIPLATIN + RALTITREXED |
| 270010415 | 270006112 | 1.88 | null | Neo-adjuvant (N) | 2015-05-18 | 2015-06-04 | CETUXIMAB + RT | N | Y | 270024981 | CARBO + FLUOROURACIL |
| 270010416 | 270006113 | null | 84.3 | null | null | 2018-02-16 | CVP R | null | null | 270024990 | VINBLASTINE |
| 270010417 | 270006114 | null | null | Palliative (P) | 2014-12-02 | 2014-12-09 | Carboplatin AUC 6 - 10 | N | N | 270024995 | CARBOPLATIN |
| 270010418 | 270006115 | 1.7 | null | Curative (C) | 2014-09-23 | 2014-10-18 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 270025015 | CARBOPLATIN + ETOPOSIDE |
| 270010419 | 270006116 | 1.73 | 113 | Curative (C) | 2013-10-03 | 2013-10-09 | Cetuximab + Radiotherapy Load | N | N | 270025017 | CAPECITABINE + OXALIPLATIN + RT |
| 270010420 | 270006117 | 1.86 | 66 | Curative (C) | 2014-05-18 | 2014-05-25 | FLUOROURACIL + MITOMYCIN + RT | N | N | 270025025 | BEVACIZUMAB + CAPECITABINE |
| 270010421 | 270006118 | 1.72 | 86 | Curative (C) | 2017-09-20 | 2017-10-12 | Oxaliplatin + Raltitrexed | N | N | 270025026 | CAP + RT |
| 270010422 | 270006119 | 1.58 | 50 | Curative (C) | 2015-04-29 | 2015-05-08 | Cetuximab + Radiotherapy Load | N | Y | 270025032 | CARBOPLATIN + ETOPOSIDE |
| 270010423 | 270006119 | 1.79 | 112.3 | Curative (C) | 2017-06-30 | 2017-07-28 | Cetuximab 7 day (Cycle 1) | N | N | 270025032 | CETUXIMAB + RT |
| 270010424 | 270006120 | 1.47 | 106.7 | Curative (C) | 2013-10-20 | 2013-10-23 | ESHAP | 2 | N | 270025045 | LOPP |
| 270010425 | 270006121 | 1.67 | null | Curative (C) | 2013-02-04 | 2013-02-11 | LOPP | N | N | 270025048 | RITUXIMAB |
| 270010426 | 270006122 | null | 98 | Disease modification (D) | 2017-10-18 | 2017-10-26 | CVP R | N | N | 270025061 | ESHAP R |
| 270010427 | 270006123 | 0 | 54.8 | Curative (C) | 2017-06-08 | 2017-06-17 | Cetuximab + Radiotherapy Load | N | Y | 270025071 | GEMCITABINE |
| 270010428 | 270012996 | 1.76 | 76 | Palliative (P) | 2016-11-05 | 2016-11-25 | Cisplatin + Fluorouracil + RT 5day | N | N | 270025074 | ECARBOX |
| 270010429 | 270006124 | 1.58 | null | Palliative (P) | 2013-10-15 | 2013-10-15 | CAPECITABINE + CARBOPLATIN | N | N | 270025089 | DOCETAXEL |
| 270010430 | 270006125 | null | null | Curative (C) | 2013-05-31 | 2013-06-03 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | N | N | 270025091 | CETUXIMAB + IRINOTECAN + MDG |
| 270010431 | 270006125 | null | 58.5 | Palliative (P) | 2015-08-09 | 2015-09-02 | Carboplatin AUC 2 - 5 | N | N | 270025091 | DOCETAXEL |
| 270010432 | 270006125 | 1.79 | 89.9 | Curative (C) | 2015-12-05 | 2015-12-13 | Cetuximab 7 day (Cycle 1) | N | N | 270025091 | CAPECITABINE + IRINOTECAN |
| 270010433 | 270006125 | null | 80.2 | Palliative (P) | null | 2017-10-31 | Capecitabine (14 days)+Carboplatin | null | null | 270025091 | CARBOPLATIN + VINORELBINE |
| 270010434 | 270018913 | 1.58 | 49.4 | Curative (C) | 2017-10-14 | 2017-10-24 | Cetuximab + Radiotherapy Load | 2 | N | 270025102 | RALTITREXED |
| 270010435 | 270006126 | 1.7 | 78.8 | Adjuvant (A) | 2016-06-08 | 2016-06-15 | FOXTROT TRIAL | N | N | 270025108 | ESHAP |
| 270010436 | 270006127 | 1.68 | 102 | Neo-adjuvant (N) | 2013-12-23 | 2013-12-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | 270025111 | CETUXIMAB + IRINOTECAN + MDG |
| 270010437 | 270012998 | 1.77 | null | Neo-adjuvant (N) | 2016-12-23 | 2016-12-31 | CISPLATIN + ETOPOSIDE | 2 | N | 270025115 | CETUXIMAB + RT |
| 270010438 | 270012998 | 1.86 | 81 | Palliative (P) | 2013-09-11 | 2013-09-13 | Cetuximab + Oxaliplatin + MdG Maint | N | N | 270025115 | CETUXIMAB |
| 270010439 | 270012998 | 1.52 | 74 | Curative (C) | 2015-11-30 | 2015-12-07 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 270025115 | CETUXIMAB + RT |
| 270010440 | 270006128 | 1.67 | 81.8 | Curative (C) | 2014-08-02 | 2014-08-26 | Cetuximab 14 day | N | N | 270025122 | CARBOPLATIN + RT |
| 270010441 | 270012999 | 1.55 | 59 | Curative (C) | 2014-12-06 | 2014-12-24 | Cisplatin + Fluorouracil + RT 5day | N | N | 270025137 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270010442 | 270006129 | 1.81 | 60 | Curative (C) | 2014-05-09 | 2014-05-09 | Capecitabine (21days) + Carboplatin | N | N | 270025138 | BEVACIZUMAB |
| 270010443 | 270006129 | 1.7 | 63.1 | Curative (C) | 2015-01-28 | 2015-02-16 | CVP R | N | Y | 270025138 | IBRUTINIB |
| 270010444 | 270006130 | null | 62.9 | Adjuvant (A) | 2015-08-14 | 2015-08-21 | Carboplatin AUC 6 - 10 | N | N | 270025145 | SCOT TRIAL |
| 270010445 | 270006131 | null | 100 | Curative (C) | null | 2016-04-11 | Cetuximab + FOLFIRI cycle1 | null | null | 270025146 | CAPECITABINE + IRINOTECAN |
| 270010446 | 270006131 | 1.67 | 90 | Palliative (P) | 2017-04-11 | 2017-04-29 | OXALIPLATIN + MDG + PANITUMUMAB | 2 | N | 270025146 | FEC + DOCETAXEL |
| 270010447 | 270006132 | 1.59 | 90.3 | Palliative (P) | 2013-03-02 | 2013-03-08 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 270025155 | GEMCARBO |
| 270010448 | 270006133 | 1.85 | 99 | Curative (C) | 2017-09-16 | 2017-09-23 | null | 2 | N | 270025157 | CVP R |
| 270010449 | 270006134 | 1.8 | 88.2 | Curative (C) | 2014-06-16 | 2014-07-14 | Ralitrexed | N | N | 270025181 | CARBOPLATIN |
| 270010450 | 270006135 | 1.81 | 69.25 | Palliative (P) | 2014-12-12 | 2014-12-15 | FLUOROURACIL + RT | N | N | 270025188 | SCOT TRIAL |
| 270010451 | 270013002 | 1.79 | 63 | Adjuvant (A) | null | 2013-03-15 | Cetuximab + Radiotherapy Load | N | N | 270025192 | CARBOPLATIN + PACLITAXEL |
| 270010452 | 270006136 | 1.7 | null | Palliative (P) | 2014-07-08 | 2014-07-08 | Carboplatin + Pemetrexed | N | N | 270025206 | CISPLATIN + FLUOROURACIL + RT |
| 270010453 | 270006137 | 1.81 | 36.4 | Adjuvant (A) | 2016-02-10 | 2016-01-13 | Ralitrexed | N | N | 270025210 | CETUXIMAB + RT |
| 270010454 | 270006138 | null | null | Palliative (P) | 2016-03-08 | 2016-03-22 | CETUXIMAB + IRINOTECAN + MDG | N | Y | 270025217 | IRINOTECAN |
| 270010455 | 270006139 | 1.63 | 77.8 | Curative (C) | 2017-04-26 | 2017-04-30 | Cetuximab + Radiotherapy Load | 02 | N | 270025219 | CAP + RT |
| 270010456 | 270006140 | 1.73 | null | null | 2014-09-01 | 2014-10-21 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 270025237 | CETUXIMAB |
| 270010457 | 270006141 | 1.6 | 58 | Curative (C) | 2013-11-30 | 2013-12-23 | Cetuximab + Radiotherapy Maint | N | null | 270025241 | FLUOROURACIL + MITOMYCIN + RT |
| 270010458 | 270013003 | 1.75 | 92.4 | Adjuvant (A) | null | 2015-03-16 | Cetuximab + Radiotherapy Load | N | N | 270025243 | CARBOPLATIN + RT |
| 270010459 | 270013003 | 1.84 | 40 | Palliative (P) | 2016-05-29 | 2016-06-03 | Bevacizumab 7.5mg/kg | N | N | 270025243 | CETUXIMAB + OXALIPLATIN + MDG |
| 270010460 | 270013003 | 1.64 | null | Palliative (P) | 2014-12-09 | 2014-12-24 | Carboplatin AUC 6 - 10 | N | N | 270025243 | CARBOPLATIN |
| 270010461 | 270006142 | 1.57 | 62.4 | Curative (C) | 2013-06-25 | 2013-07-03 | CETUXIMAB + RT | N | N | 270025269 | CAP + RT |
| 270010462 | 270006143 | 1.63 | 113 | Palliative (P) | 2015-03-15 | 2015-03-30 | CETUXIMAB | 2 | N | 270025272 | FOXTROT TRIAL |